Alexia Di Quinzio, MSc

Alexia Di Quinzio, MSc brings a unique blend of scientific rigor and business insight, shaped by experience across both scientific and investment roles in the life sciences sector. At Certara, she supports regulatory and clinical strategies through pharmacokinetic (PK) analyses such as non-compartmental analysis (NCA), dose proportionality, and bioequivalence, contributing to high-quality, submission-ready deliverables.

Before joining Certara, Alexia spent over three years at AmorChem, a Montreal-based venture capital fund, where she evaluated early-stage academic innovations for investment. Her work included scientific due diligence, intellectual property analysis, market assessment, and strategic support for portfolio companies. Earlier in her career, she held roles in GMP operations at Pharmascience Inc., where she contributed to quality system improvements and compliance training initiatives.

Alexia holds a Master of Science in Drug Development from the University of Montreal.